BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12839575)

  • 21. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis.
    Kothny-Wilkes G; Kulms D; Luger TA; Kubin M; Schwarz T
    J Biol Chem; 1999 Oct; 274(41):28916-21. PubMed ID: 10506136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.
    Guseva NV; Taghiyev AF; Sturm MT; Rokhlin OW; Cohen MB
    Mol Cancer Res; 2004 Oct; 2(10):574-84. PubMed ID: 15498932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRAIL induces apoptosis and activation of NFkappaB.
    Jeremias I; Debatin KM
    Eur Cytokine Netw; 1998 Dec; 9(4):687-8. PubMed ID: 9889416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.
    Gong B; Almasan A
    Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E; Nakazawa M; Yoshinari M; Minami M
    J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of epigenetic silencing of tumor necrosis factor-related apoptosis inducing ligand receptor 1 (DR4) to TRAIL resistance and ovarian cancer.
    Horak P; Pils D; Haller G; Pribill I; Roessler M; Tomek S; Horvat R; Zeillinger R; Zielinski C; Krainer M
    Mol Cancer Res; 2005 Jun; 3(6):335-43. PubMed ID: 15972852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platycodin D-induced apoptosis through nuclear factor-kappaB activation in immortalized keratinocytes.
    Ahn KS; Hahn BS; Kwack K; Lee EB; Kim YS
    Eur J Pharmacol; 2006 May; 537(1-3):1-11. PubMed ID: 16631160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
    Kim HS; Chang I; Kim JY; Choi KH; Lee MS
    Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions.
    Begue B; Wajant H; Bambou JC; Dubuquoy L; Siegmund D; Beaulieu JF; Canioni D; Berrebi D; Brousse N; Desreumaux P; Schmitz J; Lentze MJ; Goulet O; Cerf-Bensussan N; Ruemmele FM
    Gastroenterology; 2006 Jun; 130(7):1962-74. PubMed ID: 16762619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
    Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
    J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor necrosis factor related apoptosis inducing ligand triggers apoptosis in dividing but not in differentiating human epidermal keratinocytes.
    Jansen BJ; van Ruissen F; Cerneus S; Cloin W; Bergers M; van Erp PE; Schalkwijk J
    J Invest Dermatol; 2003 Dec; 121(6):1433-9. PubMed ID: 14675194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells.
    Oshima K; Yanase N; Ibukiyama C; Yamashina A; Kayagaki N; Yagita H; Mizuguchi J
    Cytokine; 2001 May; 14(4):193-201. PubMed ID: 11448118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.
    Wenger T; Mattern J; Penzel R; Gassler N; Haas TL; Sprick MR; Walczak H; Krammer PH; Debatin KM; Herr I
    Cell Death Differ; 2006 Oct; 13(10):1740-51. PubMed ID: 16470224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
    Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
    Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncogenic Ras sensitizes normal human cells to tumor necrosis factor-alpha-related apoptosis-inducing ligand-induced apoptosis.
    Nesterov A; Nikrad M; Johnson T; Kraft AS
    Cancer Res; 2004 Jun; 64(11):3922-7. PubMed ID: 15173003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceleration of human neutrophil apoptosis by TRAIL.
    Renshaw SA; Parmar JS; Singleton V; Rowe SJ; Dockrell DH; Dower SK; Bingle CD; Chilvers ER; Whyte MK
    J Immunol; 2003 Jan; 170(2):1027-33. PubMed ID: 12517970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
    Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.